Spots Global Cancer Trial Database for A Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma
Official Title: An Open Label, Randomized Control Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma
Study ID: NCT05220124
Conditions
Study Description
Brief Summary: A study of the efficacy and safety of probiotics in immunotherapy of urothelial carcinoma.
Detailed Description: To evaluate the progression free survival of intestinal probiotics in immunotherapy for urothelial carcinoma. Changes in fecal flora abundance before and after treatment were assessed to identify subjects most likely to benefit from enteric probiotics treatment.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Tianjin Medical University Second Hospital, Tianjin, Tianjin, China
Contact Details
Name: Hailong Hu, MD,PhD
Affiliation: Tianjin Medical University Second Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
